Literature DB >> 8005021

Genetic models of mammalian neural tube defects.

A J Copp1.   

Abstract

Several mouse mutations disturb the embryonic process of neurulation, yielding neural tube defects. Analysis of the mutations offers the most feasible approach to understanding the aetiology and pathogenesis of human neural tube defects. Interactions between the non-allelic mutant genes and between several of the mutant genes and modifying genes in the genetic background modulate the frequency and severity of the defects that develop. Environmental factors interact with the genetic predisposition either to increase or to decrease the incidence of defects. The gene loci corresponding to two of the mutations, splotch (Sp) and extra toes (Xt), have been identified as those encoding the transcription factors Pax-3 and Gli3, respectively; their human homologues are associated with Waardenburg type I syndrome and Greig's cephalopolysyndactyly. Embryological analysis reveals that several of the mutations disturb the process of neural tube closure at the posterior neuropore (in the lumbosacral region), yielding spina bifida and/or tail defects. The different mutations appear to achieve this developmental end-point by different underlying mechanisms. In curly tail (ct), non-neural tissues proliferate abnormally slowly causing ventral curvature of the neuropore region and inhibiting neural tube closure. Neural tube defects can be prevented in cultured ct/ct embryos by experimentally correcting either the proliferative imbalance or the ventral curvature. In Sp the primary defect appears to reside in the neuroepithelium. A combination of genetic analysis, gene cloning and experimental embryology is revealing that neural tube defects in mice and, by implication, in humans are a developmentally heterogeneous group of malformations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005021     DOI: 10.1002/9780470514559.ch8

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  6 in total

1.  Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2.

Authors:  T M Saxton; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

2.  Tint maps to mouse chromosome 6 and may interact with a notochordal enhancer of Brachyury.

Authors:  Jiang I Wu; M A Centilli; Gabriela Vasquez; Susan Young; Jonathan Scolnick; Larissa A Durfee; Jimmy L Spearow; Staci D Schwantz; Gabriela Rennebeck; Karen Artzt
Journal:  Genetics       Date:  2007-10       Impact factor: 4.562

3.  A phenotype-based screen for embryonic lethal mutations in the mouse.

Authors:  A Kasarskis; K Manova; K V Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

4.  Requirement of the mouse I-mfa gene for placental development and skeletal patterning.

Authors:  N Kraut; L Snider; C M Chen; S J Tapscott; M Groudine
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

Review 5.  Multiple coexistent dysraphic pathologies.

Authors:  Guirish A Solanki; James Evans; Andrew Copp; Dominic N P Thompson
Journal:  Childs Nerv Syst       Date:  2003-04-12       Impact factor: 1.475

Review 6.  Birth defects: from molecules to mechanisms.

Authors:  A J Copp
Journal:  J R Coll Physicians Lond       Date:  1994 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.